MoneyWorks4Me

Gujarat Themis Biosyn informs about disclosure of related party transactions

22 May 2021 Evaluate

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Themis Biosyn has informed that it has enclosed the disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended March 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..